US Patent Application 20080248017 - METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS
InventorsAssigneeUS Classes424/94.4, Oxidoreductases (1. ) (e.g., catalase, dehydrogenases, reductases, etc.)514/772.3, Solid synthetic organic polymer514/772.6, Carboxylic acid containing monomer514/169, Cyclopentanohydrophenanthrene ring system DOAI424/94.1, ENZYME OR COENZYME CONTAINING424/94.5, Transferases (2. ), Lyase (4.), Isomerase (5.), Ligase (6.)424/94.6, Hydrolases (3. ) (e.g., urease, lipase, asparaginase, muramidase, etc.)514/54, Polysaccharide424/184.1, ANTIGEN, EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR (E.G., IMMUNOSPECIFIC VACCINE, IMMUNOSPECIFIC STIMULATOR OF CELL-MEDIATED IMMUNITY, IMMUNOSPECIFIC TOLEROGEN, IMMUNOSPECIFIC IMMUNOSUPPRESSOR, ETC.)424/130.1, IMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIAL514/1225 or more peptide repeating units in known peptide chain structureAttorney, Agent or FirmInternational ClassesA61K 38/43A61K 47/30 A61K 47/32 A61K 38/45 A61K 31/715 A61K 39/00 A61K 38/18 A61K 39/395 A61K 38/46 A61K 38/44 A61K 31/56 Issued Patent Number:7838024Abstract textThe invention relates to an drug delivery device and a method for delivering multiple drugs over a prolonged period of time. The drug delivery device has two or more unitary segments comprising a drug-permeable polymeric substance, wherein at least one of the segments further comprises a pharmaceutically active agent. The invention also relates to a method for the treatment of a benign ovarian secretory disorder in a female mammal, a method of contraception, and a method of relieving the symptoms associated with menopausal, perimenopausal and post-menopausal periods in a woman. |
| ||||||||||||||
